1. Home
  2. NBB vs SRDX Comparison

NBB vs SRDX Comparison

Compare NBB & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBB
  • SRDX
  • Stock Information
  • Founded
  • NBB 2009
  • SRDX 1979
  • Country
  • NBB United States
  • SRDX United States
  • Employees
  • NBB N/A
  • SRDX N/A
  • Industry
  • NBB Finance Companies
  • SRDX Medical/Dental Instruments
  • Sector
  • NBB Finance
  • SRDX Health Care
  • Exchange
  • NBB Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • NBB 470.6M
  • SRDX 416.3M
  • IPO Year
  • NBB N/A
  • SRDX 1998
  • Fundamental
  • Price
  • NBB $16.14
  • SRDX $28.87
  • Analyst Decision
  • NBB
  • SRDX Buy
  • Analyst Count
  • NBB 0
  • SRDX 3
  • Target Price
  • NBB N/A
  • SRDX $43.00
  • AVG Volume (30 Days)
  • NBB 73.9K
  • SRDX 137.5K
  • Earning Date
  • NBB 01-01-0001
  • SRDX 11-05-2025
  • Dividend Yield
  • NBB 8.64%
  • SRDX N/A
  • EPS Growth
  • NBB N/A
  • SRDX N/A
  • EPS
  • NBB N/A
  • SRDX N/A
  • Revenue
  • NBB N/A
  • SRDX $120,801,000.00
  • Revenue This Year
  • NBB N/A
  • SRDX N/A
  • Revenue Next Year
  • NBB N/A
  • SRDX $3.38
  • P/E Ratio
  • NBB N/A
  • SRDX N/A
  • Revenue Growth
  • NBB N/A
  • SRDX N/A
  • 52 Week Low
  • NBB $13.67
  • SRDX $26.00
  • 52 Week High
  • NBB $16.66
  • SRDX $40.39
  • Technical
  • Relative Strength Index (RSI)
  • NBB 55.89
  • SRDX 25.36
  • Support Level
  • NBB $15.95
  • SRDX $29.54
  • Resistance Level
  • NBB $16.41
  • SRDX $30.19
  • Average True Range (ATR)
  • NBB 0.14
  • SRDX 0.74
  • MACD
  • NBB 0.00
  • SRDX -0.21
  • Stochastic Oscillator
  • NBB 51.09
  • SRDX 6.26

About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest

Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: